Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1992 Apr 1;89(7):3040–3044. doi: 10.1073/pnas.89.7.3040

Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion.

N H Guo 1, H C Krutzsch 1, E Nègre 1, T Vogel 1, D A Blake 1, D D Roberts 1
PMCID: PMC48799  PMID: 1557410

Abstract

Peptides from the three type I repeats of human endothelial cell thrombospondin, containing the consensus sequence-Trp-Ser-Xaa-Trp-, bind to sulfated glycoconjugates including heparin and sulfatide. The peptides are potent inhibitors for the binding of thrombospondin, laminin, or apolipoprotein E to these ligands. The thrombospondin peptides that inhibit heparin binding, but not adjacent peptides from the thrombospondin sequence containing the previously identified adhesive motif Val-Thr-Cys-Gly, promote melanoma cell adhesion when immobilized on plastic. Melanoma cell adhesion to the immobilized peptides is inhibited by soluble recombinant heparin-binding fragment of thrombospondin. The peptides also inhibit heparin-dependent binding of thrombospondin or laminin to human melanoma cells. The active peptides lack any previously identified heparin-binding consensus sequences and most do not contain any basic amino acids. Studies with homologous peptides showed that the tryptophan residues are required for binding. Adjacent basic residues in the second type I repeat enhance binding to heparin but not to sulfatide. Thus the type I peptides of thrombospondin define a distinct class of heparin-binding peptides.

Full text

PDF
3041

Images in this article

3042Image
on p.3042
3043Image
on p.3043
3044Image
on p.3044

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bazan J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci U S A. 1990 Sep;87(18):6934–6938. doi: 10.1073/pnas.87.18.6934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blackburn M. N., Smith R. L., Carson J., Sibley C. C. The heparin-binding site of antithrombin III. Identification of a critical tryptophan in the amino acid sequence. J Biol Chem. 1984 Jan 25;259(2):939–941. [PubMed] [Google Scholar]
  3. Bornstein P., O'Rourke K., Wikstrom K., Wolf F. W., Katz R., Li P., Dixit V. M. A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. J Biol Chem. 1991 Jul 15;266(20):12821–12824. [PubMed] [Google Scholar]
  4. Cardin A. D., Weintraub H. J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis. 1989 Jan-Feb;9(1):21–32. doi: 10.1161/01.atv.9.1.21. [DOI] [PubMed] [Google Scholar]
  5. Cygler M., Rose D. R., Bundle D. R. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science. 1991 Jul 26;253(5018):442–445. doi: 10.1126/science.1713710. [DOI] [PubMed] [Google Scholar]
  6. Dixit V. M., Grant G. A., Santoro S. A., Frazier W. A. Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin. J Biol Chem. 1984 Aug 25;259(16):10100–10105. [PubMed] [Google Scholar]
  7. Dixit V. M., Hennessy S. W., Grant G. A., Rotwein P., Frazier W. A. Characterization of a cDNA encoding the heparin and collagen binding domains of human thrombospondin. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5449–5453. doi: 10.1073/pnas.83.15.5449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Funahashi M., Matsumoto I., Seno N. Preparation of three types of heparin-sepharose and their binding activities to thrombin and antithrombin III. Anal Biochem. 1982 Nov 1;126(2):414–421. doi: 10.1016/0003-2697(82)90537-1. [DOI] [PubMed] [Google Scholar]
  9. Goundis D., Reid K. B. Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs. Nature. 1988 Sep 1;335(6185):82–85. doi: 10.1038/335082a0. [DOI] [PubMed] [Google Scholar]
  10. Holt G. D., Krivan H. C., Gasic G. J., Ginsburg V. Antistasin, an inhibitor of coagulation and metastasis, binds to sulfatide (Gal(3-SO4) beta 1-1Cer) and has a sequence homology with other proteins that bind sulfated glycoconjugates. J Biol Chem. 1989 Jul 25;264(21):12138–12140. [PubMed] [Google Scholar]
  11. Jackson R. L., Busch S. J., Cardin A. D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev. 1991 Apr;71(2):481–539. doi: 10.1152/physrev.1991.71.2.481. [DOI] [PubMed] [Google Scholar]
  12. Kaesberg P. R., Ershler W. B., Esko J. D., Mosher D. F. Chinese hamster ovary cell adhesion to human platelet thrombospondin is dependent on cell surface heparan sulfate proteoglycan. J Clin Invest. 1989 Mar;83(3):994–1001. doi: 10.1172/JCI113986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lawler J., Hynes R. O. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites and homologies with several different proteins. J Cell Biol. 1986 Nov;103(5):1635–1648. doi: 10.1083/jcb.103.5.1635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Mosher D. F. Physiology of thrombospondin. Annu Rev Med. 1990;41:85–97. doi: 10.1146/annurev.me.41.020190.000505. [DOI] [PubMed] [Google Scholar]
  15. Murphy-Ullrich J. E., Mosher D. F. Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation. J Cell Biol. 1987 Oct;105(4):1603–1611. doi: 10.1083/jcb.105.4.1603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Murphy-Ullrich J. E., Westrick L. G., Esko J. D., Mosher D. F. Altered metabolism of thrombospondin by Chinese hamster ovary cells defective in glycosaminoglycan synthesis. J Biol Chem. 1988 May 5;263(13):6400–6406. [PubMed] [Google Scholar]
  17. Prater C. A., Plotkin J., Jaye D., Frazier W. A. The properdin-like type I repeats of human thrombospondin contain a cell attachment site. J Cell Biol. 1991 Mar;112(5):1031–1040. doi: 10.1083/jcb.112.5.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rich K. A., George F. W., 4th, Law J. L., Martin W. J. Cell-adhesive motif in region II of malarial circumsporozoite protein. Science. 1990 Sep 28;249(4976):1574–1577. doi: 10.1126/science.2120774. [DOI] [PubMed] [Google Scholar]
  19. Roberts D. D., Haverstick D. M., Dixit V. M., Frazier W. A., Santoro S. A., Ginsburg V. The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids. J Biol Chem. 1985 Aug 5;260(16):9405–9411. [PubMed] [Google Scholar]
  20. Roberts D. D. Interactions of thrombospondin with sulfated glycolipids and proteoglycans of human melanoma cells. Cancer Res. 1988 Dec 1;48(23):6785–6793. [PubMed] [Google Scholar]
  21. Roberts D. D., Sherwood J. A., Ginsburg V. Platelet thrombospondin mediates attachment and spreading of human melanoma cells. J Cell Biol. 1987 Jan;104(1):131–139. doi: 10.1083/jcb.104.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sturgeon R. J., Sturgeon C. M. Affinity chromatography of sialoglycoproteins, utilising the interaction of serotonin with n-acetylneuraminic acid and its derivatives. Carbohydr Res. 1982 May 16;103(2):213–219. doi: 10.1016/s0008-6215(00)80684-9. [DOI] [PubMed] [Google Scholar]
  23. Sun X., Mosher D. F., Rapraeger A. Heparan sulfate-mediated binding of epithelial cell surface proteoglycan to thrombospondin. J Biol Chem. 1989 Feb 15;264(5):2885–2889. [PubMed] [Google Scholar]
  24. Taraboletti G., Rao C. N., Krutzsch H. C., Liotta L. A., Roberts D. D. Sulfatide-binding domain of the laminin A chain. J Biol Chem. 1990 Jul 25;265(21):12253–12258. [PubMed] [Google Scholar]
  25. Taraboletti G., Roberts D. D., Liotta L. A. Thrombospondin-induced tumor cell migration: haptotaxis and chemotaxis are mediated by different molecular domains. J Cell Biol. 1987 Nov;105(5):2409–2415. doi: 10.1083/jcb.105.5.2409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Todaro G. J., Fryling C., De Larco J. E. Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5258–5262. doi: 10.1073/pnas.77.9.5258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Vogel T., Weisgraber K. H., Zeevi M. I., Ben-Artzi H., Levanon A. Z., Rall S. C., Jr, Innerarity T. L., Hui D. Y., Taylor J. M., Kanner D. Human apolipoprotein E expression in Escherichia coli: structural and functional identity of the bacterially produced protein with plasma apolipoprotein E. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8696–8700. doi: 10.1073/pnas.82.24.8696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wharton K. A., Thomsen G. H., Gelbart W. M. Drosophila 60A gene, another transforming growth factor beta family member, is closely related to human bone morphogenetic proteins. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9214–9218. doi: 10.1073/pnas.88.20.9214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Yabkowitz R., Lowe J. B., Dixit V. M. Expression and initial characterization of a recombinant human thrombospondin heparin binding domain. J Biol Chem. 1989 Jun 25;264(18):10888–10896. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES